Drugs / ASP4058
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1 | NCT01998646 | Aug 2010 → Jul 2012 | — | Astellas Pharma Global Development, Inc. | Completed | No outcome recorded |
Evidence & citations 3 cited values
Every value below carries the sentence it was read from. 2 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | ASP4058 | ClinicalTrials.gov intervention name — accepted as the source's own label NCT01998646 ↗ |
| Modality | Small molecule | — CHEMBL4297350 ↗ |
| Route | Oral | “Oral tablet” NCT01998646 ↗ |